Structural elucidation of degradation products of a benzopyridooxathiazepine under stress conditions using electrospray orbitrap mass spectrometry – Study of degradation kinetic (original ) (raw )Identification of degradation products of saquinavir mesylate by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry and its application to quality control
Dr Debasish Swain
Rapid Communications in Mass Spectrometry, 2017
View PDFchevron_right
The use of liquid chromatography±mass spectrometry for the identi®cation of drug degradation products in pharmaceutical formulations
Marco Garzotti
View PDFchevron_right
Identification of stress degradation products of iloperidone using liquid chromatography coupled with an Orbitrap mass spectrometer
Tofan Rout
Rapid communications in mass spectrometry : RCM, 2017
View PDFchevron_right
Slow, spontaneous degradation of lansoprazole, omeprazole and pantoprazole tablets: isolation and structural characterization of the toxic antioxidants 3H-benzimidazole-2-thiones
Marwan Touma
View PDFchevron_right
Use of LC–MS/TOF, LC–MSn, NMR and LC–NMR in characterization of stress degradation products: Application to cilazapril
Archana Sahu
Journal of Pharmaceutical and Biomedical Analysis, 2015
View PDFchevron_right
Kinetic study on the degradation of prazepam in acidic aqueous solutions by high-performance liquid chromatography and fourth-order derivative ultraviolet spectrophotometry
Irene Panderi
Journal of Pharmaceutical and Biomedical Analysis, 1998
View PDFchevron_right
Degradation studies of quetiapine fumarate by liquid chromatography–diode array detection and tandem mass spectrometry methods
Marta De Diego
Biomedical Chromatography, 2019
View PDFchevron_right
Identification of Degradation Products in Cyclophosphamide API by LC-QTOF Mass Spectrometry Identification of Degradation Products in Cyclophosphamide API by LC-QTOF Mass Spectrometry
shiva gudlawar
View PDFchevron_right
Identification and Characterization of Degradation Products of Lacosamide by Liquid-Chromatography/Time-Of-Flight Mass Spectrometric and Multi-Stage Mass Spectrometric Analysis
Ritesh Bhole
Journal of Liquid Chromatography & Related Technologies, 2014
View PDFchevron_right
Characterization of imazamox degradation by-products by using liquid chromatography mass spectrometry and high-resolution Fourier transform ion cyclotron resonance mass spectrometry
András Gáspár
Analytical and Bioanalytical Chemistry, 2007
View PDFchevron_right
Structure elucidation of degradation products of the antibiotic amoxicillin with ion trap MSn and accurate mass determination by ESI TOF
Dr S. Venkat Rao
Journal of the American Society for Mass Spectrometry, 2005
View PDFchevron_right
Study of Forced Degradation Behaviour of Brinzolamide Using LC–ESI–Q-TOF and In Silico Toxicity Prediction
Dr Debasish Swain
Chromatographia, 2016
View PDFchevron_right
Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: Application to valsartan, a model drug
Saranjit Singh
Drug Testing and Analysis, 2010
View PDFchevron_right
Ultraviolet-photodiode array and high-performance liquid chromatographic/mass spectrometric studies on forced degradation behavior of glibenclamide and development of a validated stability-indicating method
Saranjit Singh
Journal of AOAC International
View PDFchevron_right
Identification, Isolation, and Structural Characterization of Novel Forced Degradation Products of Darunavir Using Advanced Analytical Techniques Like UPLC–MS, Prep-HPLC, HRMS, NMR, and FT-IR Spectroscopy
Ramusamineni Sri
Chromatographia
View PDFchevron_right
LC-MS/MS structural characterization of stress degradation products including the development of a stability indicating assay of Darunavir: An anti-HIV drug
Dr. Bondigalla Ramachandra
Journal of Pharmaceutical and Biomedical Analysis, 2014
View PDFchevron_right
LC, LC-MS/MS studies for the identification and characterization of degradation products of hydrochlorothiazide and establishment of mechanistic approach towards degradation
Sandeep Kale
Journal of the Brazilian Chemical Society, 2012
View PDFchevron_right
Forced degradation study of efonidipine HCl ethanolate, characterization of degradation products by LC-Q-TOF-MS and NMR
Charu Pandya
Journal of Applied Pharmaceutical Science, 2020
View PDFchevron_right
Forced Degradation Study of Quinapril by UPLC-DAD and UPLC/ MS/MS: Identification of By-products and Development of Degradation Kinetics
Maha Dendeni
Current Pharmaceutical Analysis, 2013
View PDFchevron_right
Forced degradation studies of lansoprazole using LC-ESI HRMS and 1 H-NMR experiments: in vitro toxicity evaluation of major degradation products
Nagesh Narayana
Journal of Mass Spectrometry, 2017
View PDFchevron_right
LC, MS n and LC-MS/MS studies for the characterization of degradation products of amlodipine
Anand Avinash Mahajan
Journal of pharmaceutical analysis, 2015
View PDFchevron_right
IDENTIFICATION, SEPARATION, AND CHARACTERIZATION OF DEGRADATION PRODUCTS OF TRIAMCINOLONE HEXACETONIDE USING LC AND LC-MS/MS
International Journal of Applied Pharmaceutics (IJAP) , BHAVNA SUNIL MAHAJAN
International Journal of Applied Pharmaceutics, 2024
View PDFchevron_right
Forced degradation study of different brands of levocetirizine dihydrochloride by UV-spectroscopy
Zamir Khan
International Journal of Pharmaceutical Chemistry and Analysis, 2020
View PDFchevron_right
An Introduction to Forced degradation studies for drug substances and drug products
MUSKAN singh
Journal of emerging technologies and innovative research, 2021
View PDFchevron_right
Review: Development of forced degradation studies of drugs
Scholar Science Journals
View PDFchevron_right
Utilisation of electrospray time-of-flight mass spectrometry for solving complex fragmentation patterns: application to benzoxazinone derivatives
Thomas Knepper
Journal of Mass Spectrometry, 2003
View PDFchevron_right
HPLC–DAD method for investigating pantoprazole for its stress-dependent degradation by photolysis and oxidation
Neelaveni Thangavel
Acta Chromatographica, 2020
View PDFchevron_right
MS/MS and HPLC characterization of forced degradation products of clopidogrel and pantoprazole sodium
Jinesh Nagavi
International Journal of Drug Development and Research, 2018
View PDFchevron_right
Column liquid chromatography-ultraviolet and column liquid chromatography/mass spectrometry evaluation of stress degradation behavior of escitalopram oxalate
Prof Dr Sunil Dhaneshwar
Journal of AOAC International
View PDFchevron_right
Forced Degradation Study for Simultaneous Quantification of Aspirin and Omeprazole in Pharmaceutical Dosage form by RP-HPLC
chandni chandarana
Journal of Pharmaceutical Research International
View PDFchevron_right
Electrochemical oxidation coupled with liquid chromatography and mass spectrometry to study the oxidative stability of active pharmaceutical ingredients in solution: A comparison of off-line and on-line approaches
Roman Szucs
Journal of pharmaceutical and biomedical analysis, 2016
View PDFchevron_right
Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry
Jean-claude Tabet
Rapid communications in mass spectrometry : RCM, 2018
View PDFchevron_right
Isolation, identification, and synthesis of two oxidative degradation products of olanzapine (LY170053) in solid oral formulations
craig kemp
Journal of Pharmaceutical Sciences, 2008
View PDFchevron_right